Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 137

1.

Why public health agencies cannot depend on good laboratory practices as a criterion for selecting data: the case of bisphenol A.

Myers JP, vom Saal FS, Akingbemi BT, Arizono K, Belcher S, Colborn T, Chahoud I, Crain DA, Farabollini F, Guillette LJ Jr, Hassold T, Ho SM, Hunt PA, Iguchi T, Jobling S, Kanno J, Laufer H, Marcus M, McLachlan JA, Nadal A, Oehlmann J, Olea N, Palanza P, Parmigiani S, Rubin BS, Schoenfelder G, Sonnenschein C, Soto AM, Talsness CE, Taylor JA, Vandenberg LN, Vandenbergh JG, Vogel S, Watson CS, Welshons WV, Zoeller RT.

Environ Health Perspect. 2009 Mar;117(3):309-15. doi: 10.1289/ehp.0800173. Epub 2008 Oct 22.

PMID:
19337501
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

A new approach to synergize academic and guideline-compliant research: the CLARITY-BPA research program.

Schug TT, Heindel JJ, Camacho L, Delclos KB, Howard P, Johnson AF, Aungst J, Keefe D, Newbold R, Walker NJ, Thomas Zoeller R, Bucher JR.

Reprod Toxicol. 2013 Sep;40:35-40. doi: 10.1016/j.reprotox.2013.05.010. Epub 2013 Jun 5. Review.

PMID:
23747832
[PubMed - indexed for MEDLINE]
3.

Low dose effects and non-monotonic dose responses for endocrine active chemicals: science to practice workshop: workshop summary.

Beausoleil C, Ormsby JN, Gies A, Hass U, Heindel JJ, Holmer ML, Nielsen PJ, Munn S, Schoenfelder G.

Chemosphere. 2013 Oct;93(6):847-56. doi: 10.1016/j.chemosphere.2013.06.043. Epub 2013 Aug 9.

PMID:
23932820
[PubMed - indexed for MEDLINE]
Free Article
4.

Basic exploratory research versus guideline-compliant studies used for hazard evaluation and risk assessment: bisphenol A as a case study.

Tyl RW.

Environ Health Perspect. 2009 Nov;117(11):1644-51. doi: 10.1289/ehp.0900893. Epub 2009 Jun 29.

PMID:
20049112
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Biomonitoring studies should be used by regulatory agencies to assess human exposure levels and safety of bisphenol A.

Vandenberg LN, Chahoud I, Padmanabhan V, Paumgartten FJ, Schoenfelder G.

Environ Health Perspect. 2010 Aug;118(8):1051-4. doi: 10.1289/ehp.0901717. Epub 2010 May 5.

PMID:
20444668
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Conclusions of the French Food Safety Agency on the toxicity of bisphenol A.

Arnich N, Canivenc-Lavier MC, Kolf-Clauw M, Coffigny H, Cravedi JP, Grob K, Macherey AC, Masset D, Maximilien R, Narbonne JF, Nesslany F, Stadler J, Tulliez J.

Int J Hyg Environ Health. 2011 Jun;214(3):271-5. doi: 10.1016/j.ijheh.2010.12.002. Epub 2011 Jan 7. Review.

PMID:
21216193
[PubMed - indexed for MEDLINE]
7.

Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.

EFSA GMO Panel Working Group on Animal Feeding Trials.

Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. doi: 10.1016/j.fct.2008.02.008. Epub 2008 Feb 13. Review.

PMID:
18328408
[PubMed - indexed for MEDLINE]
8.

Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A.

Hengstler JG, Foth H, Gebel T, Kramer PJ, Lilienblum W, Schweinfurth H, Völkel W, Wollin KM, Gundert-Remy U.

Crit Rev Toxicol. 2011 Apr;41(4):263-91. doi: 10.3109/10408444.2011.558487. Review.

PMID:
21438738
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

ECETOC Florence workshop on risk assessment of endocrine substances, including the potency concept.

Fegert I.

Toxicol Lett. 2013 Dec 16;223(3):310-4. doi: 10.1016/j.toxlet.2013.03.027. Epub 2013 Apr 1.

PMID:
23558296
[PubMed - indexed for MEDLINE]
10.

An evaluation of evidence for the carcinogenic activity of bisphenol A.

Keri RA, Ho SM, Hunt PA, Knudsen KE, Soto AM, Prins GS.

Reprod Toxicol. 2007 Aug-Sep;24(2):240-52. Epub 2007 Jun 28. Review.

PMID:
17706921
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Bisphenol A: a body of evidence supporting exposure reduction.

[No authors listed]

Prescrire Int. 2013 Sep;22(141):219-23.

PMID:
24171222
[PubMed - indexed for MEDLINE]
12.

U.S. Food and Drug Administration perspective of the inclusion of effects of low-level exposures in safety and risk assessment.

Gaylor DW, Bolger PM, Schwetz BA.

Environ Health Perspect. 1998 Feb;106 Suppl 1:391-4. Review.

PMID:
9539036
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

A comparison of the U.S. EPA FIFRA GLP standards with the U.S. FDA GLP standards for nonclinical laboratory studies.

Keatley KL.

Qual Assur. 1999 Jul-Sep;7(3):147-54.

PMID:
11033740
[PubMed - indexed for MEDLINE]
14.

Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry.

Tong EK, England L, Glantz SA.

Pediatrics. 2005 Mar;115(3):e356-66.

PMID:
15741361
[PubMed - indexed for MEDLINE]
15.

Large effects from small exposures. II. The importance of positive controls in low-dose research on bisphenol A.

vom Saal FS, Welshons WV.

Environ Res. 2006 Jan;100(1):50-76. Epub 2005 Oct 27.

PMID:
16256977
[PubMed - indexed for MEDLINE]
16.

Risk to all or none? A comparative analysis of controversies in the health risk assessment of Bisphenol A.

Beronius A, Rudén C, Håkansson H, Hanberg A.

Reprod Toxicol. 2010 Apr;29(2):132-46. doi: 10.1016/j.reprotox.2009.11.007. Epub 2009 Nov 18.

PMID:
19931376
[PubMed - indexed for MEDLINE]
17.

Does rapid metabolism ensure negligible risk from bisphenol A?

Ginsberg G, Rice DC.

Environ Health Perspect. 2009 Nov;117(11):1639-43. doi: 10.1289/ehp.0901010. Epub 2009 Jul 14.

PMID:
20049111
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Risk management frameworks for human health and environmental risks.

Jardine C, Hrudey S, Shortreed J, Craig L, Krewski D, Furgal C, McColl S.

J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. Review.

PMID:
14698953
[PubMed - indexed for MEDLINE]
19.

Guidelines, editors, pharma and the biological paradigm shift.

Singh AR, Singh SA.

Mens Sana Monogr. 2007 Jan;5(1):27-30. doi: 10.4103/0973-1229.32176.

PMID:
22058616
[PubMed]
Free PMC Article
20.

Procedures and methods of benefit assessments for medicines in Germany.

Bekkering GE, Kleijnen J.

Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.

PMID:
18987905
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk